InvestSMART

Paradigm Biopharmaceuticals Limited (ASX: PAR) - Announcements

Current share price for PAR : $0.245 0.005 (2%)+

ASX company news and announcements for Paradigm Biopharmaceuticals Limited (PAR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Paradigm Biopharmaceuticals Limited (PAR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Paradigm Biopharmaceuticals Limited (PAR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Paradigm Biopharmaceuticals Limited (PAR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$153 PAR Selected for Major OA Conference Presentations 30 Jan 2024 9:12AM $0.405 $0.245 fallen by 39.51%
$153 Notice of release of escrowed securities 15 Jan 2024 6:46PM $0.400 $0.245 fallen by 38.75%
$153 Change in substantial holding 6 Dec 2023 5:08PM $0.395 $0.245 fallen by 37.97%
$153 Change of Director's Interest Notice - Fisher 1 Dec 2023 11:04AM $0.390 $0.245 fallen by 37.18%
$153 Change of Director's Interest Notice - Rennie 30 Nov 2023 2:50PM $0.390 $0.245 fallen by 37.18%
$153 Notification of cessation of securities - PAR 30 Nov 2023 11:55AM $0.385 $0.245 fallen by 36.36%
$153 Application for quotation of securities - PAR 30 Nov 2023 11:48AM $0.390 $0.245 fallen by 37.18%
$153 Results of Meeting 29 Nov 2023 2:36PM $0.390 $0.245 fallen by 37.18%
$153 2023 AGM Company Update 29 Nov 2023 8:43AM $0.390 $0.245 fallen by 37.18%
$153 2023 AGM Chairman Address 29 Nov 2023 8:39AM $0.390 $0.245 fallen by 37.18%
$153 Security Class Reinstatement to Quotation PARO 28 Nov 2023 9:22AM $0.385 $0.245 fallen by 36.36%
$153 Listing of Options - Top 20 Holders and Distribution Reports 27 Nov 2023 12:57PM $0.388 $0.245 fallen by 36.77%
$153 Application for quotation of securities - PAR 27 Nov 2023 11:43AM $0.390 $0.245 fallen by 37.18%
$153 Successful completion of Retail Entitlement Offer 23 Nov 2023 2:17PM $0.395 $0.245 fallen by 37.97%
$153 Security Class Suspension from Quotation PARO 21 Nov 2023 8:49AM $0.405 $0.245 fallen by 39.51%
$153 Application for quotation of securities - PAR 20 Nov 2023 5:23PM $0.405 $0.245 fallen by 39.51%
$153 PAR Pre-AGM Update 20 Nov 2023 12:39PM $0.405 $0.245 fallen by 39.51%
$153 Notice of release of escrowed securities 10 Nov 2023 4:21PM $0.385 $0.245 fallen by 36.36%
$153 Application for quotation of securities - PAR 8 Nov 2023 11:35AM $0.400 $0.245 fallen by 38.75%
$153 Retail Entitlement Offer Open 6 Nov 2023 8:28AM $0.430 $0.245 fallen by 43.02%
$153 Addendum to Notice of Meeting 3 Nov 2023 8:20AM $0.430 $0.245 fallen by 43.02%
$153 Paradigm to Recommence Trading 1 Nov 2023 8:43AM $0.615 $0.245 fallen by 60.16%
$153 Proposed issue of securities - PAR 31 Oct 2023 12:15PM $0.615 $0.245 fallen by 60.16%
$153 Update - Proposed issue of securities - PAR 31 Oct 2023 12:04PM $0.615 $0.245 fallen by 60.16%
$153 Replacement Entitlement Offer and Placement Prospectus 31 Oct 2023 12:04PM $0.615 $0.245 fallen by 60.16%

201 - 225 of 732 results

Page 9 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.